Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

被引：0
|
作者：
赵小利 [1 ]
机构：
[1] Instit Hemato & Blood Dis Hosp,CAMS & PUMC
来源：
China Medical Abstracts (Internal Medicine) | 2019年 / 36卷 / 03期
关键词：
AML; Decitabine-based conditioning regimen is feasible and effective in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia;
D O I：
暂无
中图分类号：
R733.7 [白血病]; R551.3 [骨髓疾病];
学科分类号：
1002 ; 100201 ; 100214 ;
摘要：
Objective To assess the efficacy and toxicity of decitabine-based conditioning regimen in patients with myelodysplastic syndrome (MDS),acute myeloid leukemia secondary to MDS (MDS-AML) or chronic myelomonocytic leukemia (CMML). Methods From March
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [21] Oral Decitabine/Cedazuridine with Venetoclax in High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia: Analysis By Different Response Criteria
    Bataller, Alex
    Montalban-Bravo, Guillermo
    Bazinet, Alexandre
    Valero, Yesid Alvarado
    Chien, Kelly S.
    Venugopal, Sangeetha
    Ishizawa, Jo
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Issa, Ghayas C.
    Short, Nicholas J.
    Masarova, Lucia
    Daver, Naval
    Kadia, Tapan M.
    Colla, Simona
    Qiao, Wei
    Huang, Xuelin
    Kanagal-Shamanna, Rashmi
    Hendrickson, Stephany
    Ravandi, Farhad
    Jabbour, Elias
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2023, 142
  • [22] Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment
    Yi, Jun Ho
    Huh, Jungwon
    Kim, Hee-Jin
    Kim, Sun-Hee
    Kim, Sung Hyun
    Kim, Kyoung Ha
    Do, Young Rok
    Mun, Yeung-Chul
    Kim, Hawk
    Kim, Min Kyoung
    Kim, Hyeoung-Joon
    Kim, TaeHyung
    Kim, Dennis Dong Hwan
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 459 - 469
  • [23] Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment
    Jun Ho Yi
    Jungwon Huh
    Hee-Jin Kim
    Sun-Hee Kim
    Sung Hyun Kim
    Kyoung Ha Kim
    Young Rok Do
    Yeung-Chul Mun
    Hawk Kim
    Min Kyoung Kim
    Hyeoung-Joon Kim
    TaeHyung Kim
    Dennis Dong Hwan Kim
    Annals of Hematology, 2013, 92 : 459 - 469
  • [24] Clinical Study of Allo-HSCT with Conditioning Regimen Containing Decitabine in the Treatment of advanced Acute Myloid Leukemia and Myelodysplastic Syndrom
    Shi, Xiaojing
    Sun, Aining
    Zhu, Xiaming
    Qiu, Huiying
    Jin, Zhengming
    Miao, Miao
    Fu, Chengcheng
    Ma, Xiao
    Chen, Feng
    Xue, Shengli
    Ruan, Changgeng
    Wu Depei
    Tang, Xiaowen
    BLOOD, 2014, 124 (21)
  • [25] Topotecan, a topoisomerase I inhibitor, is a active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Beran, M
    OBrien, S
    Arbuck, S
    Pierce, S
    Keating, M
    Kantarjian, H
    BLOOD, 1995, 86 (10) : 1335 - 1335
  • [26] FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
    Daver, Naval
    Strati, Paolo
    Jabbour, Elias
    Kadia, Tapan
    Luthra, Raja
    Wang, Sa
    Patel, Keyur
    Ravandi, Farhad
    Cortes, Jorge
    Dong, Xiao Qin
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (01) : 56 - 59
  • [27] Vasculitis in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia: A Report of Two Cases
    Jacobse, Justin
    Sijpkens, Yvo W. J.
    van 't Wout, Jan W.
    Peters, Elke E. M.
    Vlasveld, L. Tom
    JOURNAL OF HEMATOLOGY, 2018, 7 (04) : 158 - 162
  • [28] UNICENTRIC EXPERIENCE IN THE COMBINED AND INDIVIDUAL USE OF AZACITIDINE AND DECITABINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    Lerma Verdejo, A.
    Martinez Moya, M. D.
    Luts, I
    Ustariz, M., I
    Solano Ramos, F.
    HAEMATOLOGICA, 2019, 104 : 294 - 294
  • [29] Glasdegib Hedgehog signaling inhibitor Treatment of myelodysplastic syndrome Treatment of chronic myelomonocytic leukemia Treatment of acute myeloid leukemia Treatment of myelofibrosis
    Gras, J.
    DRUGS OF THE FUTURE, 2017, 42 (05) : 265 - 274
  • [30] A case of sudden hearing loss during treatment with decitabine for chronic myelomonocytic leukemia
    Kim, Hee-Jun
    Park, Eun-Kyung
    Moon, In-Seok
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : E1 - E4
12345